Skip to Main Content

Contribute Try STAT+ Today

NIH

Most Read

US Covid Surveillance

Health By Megan Molteni

‘Just stupid stuff’: Logistics and lack of testing stymied finding the Omicron variant in the U.S.

antiviral

Pharmalot By Ed Silverman

Former Immunomedics executives are charged with insider trading

J WOODCOCK

Politics By Nicholas Florko

Califf, nominee to lead FDA, asks Woodcock to stay in leadership role if he’s confirmed

Health Tech By Katie Palmer

Virtual care companies rush to ease access to Covid-19 antivirals

The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein

Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron

Capitol reflection public health

Politics By Rachel Cohrs

Hospitals and doctors fail to stop end-of-year Medicare cuts, for now

Health By Andrew Joseph

Second U.S. case of Omicron variant indicates domestic transmission

In the Lab By Megan Molteni

Most advanced lab-grown human embryos prompt a pressing question: Are they getting too real?

All Coverage

ME/CFS Demonstration

First Opinion By Jennifer Spotila

The NIH is thwarting research on a poorly understood yet serious condition

George Koob photo illustration

Exclusive By Sharon Begley and Andrew Joseph

New alcohol-advertising research stopped with NIH branch director’s arrival

advertisement

Binge-drinking research

Exclusive By Sharon Begley

NIH rejected a study of alcohol advertising while pursuing industry funding for other research

Framingham Heart Study

First Opinion By Jeffrey A. Bluestone, David Beier and Laurie H. Glimcher

The NIH is in danger of losing its edge in creating biomedical innovations

D.C. Insight IMAGE

Politics By Lev Facher

Research leaders: We need to roll up our sleeves, not roll our eyes

Adriana Landeros

Video By Hyacinth Empinado

Watch: She went from drug courier to inmate to researcher marching for science

NIH Headquarters

Politics By Dylan Scott

White House proposes new, sweeping budget cuts at NIH

Rep. Tom Cole

Politics By Dylan Scott

Now that Trump has proposed big NIH cuts, it’s Congress’s turn

NIH headquarters

Politics By Dylan Scott

How Trump’s proposed NIH cuts could actually play out

D.C. Insight IMAGE

Politics By Dylan Scott

NIH supporters worry: Will research get a funding increase this year?

Barack Obama, Francis Collins

Politics By Dylan Scott

Key Republicans urge Trump to keep Francis Collins as NIH director

Newt Gingrich

Politics By Dylan Scott

Medical research’s best hope under President Trump? It’s Newt

Congress

Politics By Sheila Kaplan

Trump’s victory is a likely roadblock to medical ‘cures’ package

Trump/Pence future

Politics By Sharon Begley

Fearful of a Trump administration, many in research call for a ‘tutorial’ for the president-elect

NIH Headquarters

Politics By Charles Piller

New federal rules target woeful public reporting of clinical trial results

Murthy & Burwell

Politics By David Nather

Obama administration, shifting money to fight Zika, says funds are tapped out

Embryonic stem cell gene edit

In the Lab By Andrew Joseph

NIH considering restarting funding for human-animal chimera research

Chirlane McCray

Health By Dylan Scott

New York City’s first lady explains why she’s so open about mental illness

Dr. Anthony Fauci

In the Lab By Andrew Joseph

US researchers now testing Zika vaccines in human subjects

Canadian Health Minister Jane Philpott

In the Lab By Carolyn Abraham

An ugly summer for science: Turmoil rocks Canadian research community

woman scientist in laboratory

Quick Take By Lindzi Wessel

Female scientists face gender bias in NIH grant process

Healthcare bill

Health By Emily Bazar — Kaiser Health News

Government listing of clinical trials doesn’t disclose costs to patients

Columbia University

In the Lab By Sheila Kaplan

Columbia University fined nearly $10 million for sending inflated bills to NIH

Rep. Tom Cole

Politics By Dylan Scott

House panel set to endorse $1.3 billion increase for the NIH

Clinical trials

In the Lab By Sheila Kaplan

In clinical trials, for-profit review boards are taking over for hospitals. Should they?